“…Consistent with this trend, the ratio of multifocal (bifocal or trifocal), or extended depth-of-focus (EDOF) IOL implantations is increasing [4]. Different bifocal IOL platforms were implanted in the past, but currently, the most common presbyopia correcting IOLs implanted, include on the one hand the trifocal models, like the PanOptix (Alcon Laboratories Inc., Fort Worth, TX, USA), Fine-Vision Micro F IOL (PhysIOL, Liège, Belgium), Acriva Reviol Tri-ED 611 (VSY Biotechnology, Amsterdam, The Netherlands), and AT Lisa tri (Carl Zeiss Meditec AG, Jena, Germany), and on the other hand, modern EDOF like the Symfony (Johnson & Johnson Vision Inc., Santa Ana, CA, USA), or Vivity (Alcon Laboratories Inc., Fort Worth, TX, USA) IOLs [4,5].…”